{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16236",
      "entity_text" : "Nrf2",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P18428",
      "entity_text" : "LBP",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "As shown in XREF_FIG A, the immunohistochemical study demonstrated that the LBP treatment could dramatically increase the percentage of Nrf2 positive cells when compared with the LPS group (P < 0.001), which can be successfully reversed by the brusatol treatment.",
  "reading_complete" : "2020-08-05T19:52:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:51:40Z",
  "trigger" : "increase",
  "evidence" : [ "LBP treatment could dramatically increase the percentage\nof Nrf2" ],
  "pmc_id" : "6585919",
  "score" : 0
}